Denmark vs Saudi Arabia: Access to anti-retroviral drugs, female
Denmark
91.0%
in 2023
Saudi Arabia
91.0%
in 2024
Denmark rank
25th
Saudi Arabia rank
25th
Access to anti-retroviral drugs, female over time
- Denmark
- Saudi Arabia
How they compare
Denmark currently reports 91.0% against 91.0% in Saudi Arabia, a difference of 0.0%.
Across all 24 years both countries report, Denmark has been ahead every year.
Denmark ranks 25th and Saudi Arabia ranks 25th of 141 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 24.3% | 26.7% | Denmark |
| 2010s | 77.9% | 62.5% | 15.4% | Denmark |
| 2020s | 88.0% | 81.2% | 6.8% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Denmark or Saudi Arabia?
- Denmark, at 91.0% against 91.0% in Saudi Arabia as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Denmark and Saudi Arabia?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Saudi Arabia?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Saudi Arabia rank globally for access to anti-retroviral drugs, female?
- Denmark ranks 25th and Saudi Arabia ranks 25th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.